News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_approved_web.jpg)
FDA okays ubrogepant for acute migraine treatment
- Author:
- Megan Brooks
ACHIEVE I and ACHIEVE II demonstrate efficacy.
News
FDA expands use of Toujeo to childhood type 1 diabetes
- Author:
- Megan Brooks
Publish date: December 4, 2019
Numerically fewer patients taking Toujeo experienced severe hypoglycemia or experienced one or more episodes of...
News
Addressing current asthma management: What clinicians told us
- Author:
- Megan Brooks
Publish date: June 12, 2019
Survey respondents ranked an inhaled corticosteroid with a long-acting bronchodilator as the favored medication for patients with moderate to...
News
Considering Costs U.S. Hospitals choose Anticoagulant Rivaroxaban Over Warfarin
- Author:
- Megan Brooks
- Reuters Health
NEW YORK (Reuters Health) - U.S. hospitals save money when they use the novel oral anticoagulant rivaroxaban instead of warfarin to treat patients...
News
Study Shows ICDs Benefit Women in Heart Failure Prevention
- Author:
- Megan Brooks
NEW YORK (Reuters Health)—Women with heart failure (HF) derive as much benefit from implantable cardiac defibrillators (ICDs) for primary...
News
Elderly Patients with Pneumonia Benefit from ICU Care
- Author:
- Megan Brooks
- Reuters Health
NEW YORK - Elderly patients with pneumonia whose need for intensive care unit (ICU) admission is uncertain actually fare better in the ICU than on...